Non-compendial vs compendial analytical tests - a powerful tool for predicting in vitro similarity of highly viscous oral suspension
-
Published:2019
Issue:02
Volume:64
Page:61-72
-
ISSN:1857-8969
-
Container-title:Macedonian Pharmaceutical Bulletin
-
language:en
-
Short-container-title:Maced. Pharm. Bull.
Author:
Kazandjievska Elena1, Antova Iva1, Mitrevska Slavica1, Dimkovski Aleksandar1, Dimov Elena1, Hadzieva Gigovska Maja1, Antovska Packa1, Ugarkovic Sonja1, Tonic Ribarska Jasmina2, Trajkovic-Jolevska Suzana2
Affiliation:
1. Research & Development, ALKALOID AD Skopje, Blvd. Aleksandar Makedonski 12, 1000 Skopje, R. North Macedonia 2. Faculty of Pharmacy, Ss. Cyril and Methodius University, Mother Theresa 47, 1000 Skopje, R. North Macedonia
Abstract
In vitro dissolution profiles are increasingly used to evaluate drug release characteristics of pharmaceutical products. The dissolution methods is expected to be an appropriate tool for checking consistency of the pharmaceutical attributes by discriminating similarities and dissimilarities between different drug formulations. Expansion in development of novel “special” dosage forms, due to the manner in which these dosage forms release the active pharmaceutical ingredient, usually requires applying non-compendial dissolution strategy that differs from the traditional compendial recommendations.
For demonstrating sameness in the dissolution profile, in vitro drug release comparison between test and reference product of highly viscous oral suspension by applying non-compendial peak vessel against conventional hemispheric vessel was demonstrated in this study.
All reference batches exhibited high variability in dissolution data when using hemispheric vessel due to forming mound compact mass at the bottom of the vessel. Different strategies for samples manipulation, before and during dissolution period, were performed in order to eliminate additional variabilities. Modifications of conventional USP 2 apparatus such as using peak vessel provided with more reproducible and reliable result for distinguishing in vitro similarities between different formulations of oral suspensions.
Misinterpretation of dissolution data can lead to negative impact on product development. Taking time to observe and evaluate what is happening to the product in the vessel during dissolution is of curtail consideration for proper selection of the dissolution strategy.
Keywords: oral suspensions; in-vitro release; hydrodynamic variability; USP apparatus 2/ Paddle apparatus; peak vessel
Publisher
Macedonian Pharmaceutical Association
Reference13 articles.
1. Brown, C.K., Chokshi, H.P., Nickerson, B., Reed, R.A., Rohs, B.R., Shan, P.A., 2004. Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds. Dissolution Technologies 28(12), 56. Available at: https://doi.org/10.14227/DT120405P6. 2. Brown, C.K., Friedel, H.D., Barker, A.R., Buhse, L.F., Keitel, S., Cecil, T.L., Kraemer, J., Morris, J.M., Reppas, C., Stickelmeyer, M.P., Yomota, C., Shah, V.P., 2011. FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms. Indian Journal of Pharmaceutical Sciences 73(3), 338–353. 3. Collins, C.C. and Nair, R.R., 1998. Comparative evaluation of mixing dynamics in USP apparatus 2 using standard USP vessels and PEAKTM vessel. Dissolution Technologies 5(2), 17–21. Available at: https://doi.org/10.14227/DT050298P17. 4. CPMP/EWP/QWP/1401/98 Rev.1, E.M. Agency, 2010. Guideline on the investigation of bioequivalence. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf. 5. Fotaki, N. and Vertzoni, M., 2010. Biorelevant Dissolution Methods and Their Applications in In Vitro-In Vivo Correlations for Oral Formulations. The Open Drug Delivery Journal 4(2), 2–13. Available at: https://doi.org/10.2174/1874126601004020002.
|
|